ArticleOncotarget2024

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.

Yunfei Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.